Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Calls for NHS to ‘referee’ shortages data sharing

Health service must take the lead in persuading supply chain to share information so problem does not get worse, pharmacy sector says

The NHS must take the lead in persuading every member of the pharmacy supply chain to share data on medicine shortages to stop them getting even worse, pharmacists and wholesalers have warned.

Their calls followed a review into European shortages published this month by Swiss management consultancy firm Birgli. An informed decision on how to tackle the problem could only be made if manufacturers, wholesalers and pharmacists across Europe shared their data, the review concluded.  

The British Association of Pharmaceutical Wholesalers (BAPW) and Community Pharmacy West Yorkshire chief executive Robbie Turner said the NHS would need to persuade businesses to share their data, which included commercially sensitive information.



The NHS should be able to set up a system to collect data on shortages from businesses, says BAPW chief executive Martin Sawer


More on shortages

Europe-wide data sharing needed to prevent shortages worsening

Deeds not words on shortages

BAPW overhauls standards to address supply chain weaknesses

MORE NEWS

"The challenge is that when you're trying to exchange data between parts of the supply chain that have commercial relationships, it really takes a referee – someone who can shine that light on the whole sector," said BAPW chief executive Martin Sawer.

The NHS already collected data from the supply chain and should be able to set up a system to collect data on shortages from companies, he told C+D.

Mr Turner agreed it would require "national leadership" from the Department of Health to get companies to give up their data.

"Trying to get everyone to agree to the same thing at the same time is always difficult, never mind when it's such a contentious issue," he told C+D.

The European Federation of Pharmaceutical Industries and Associations (EFPIA) said it was willing to contribute to a "comprehensive notification system" that made it easier for patients and healthcare providers to predict shortages.

This would require every member of the supply chain to provide information on medicines supplies "in a timely manner", an EFPIA spokesperson said.

Shortages were getting worse in every country in Europe and improved communication between European regulators and supply chain stakeholders was "critical" in resolving the situation, the Birgli review said.

The Department of Health (DH) did not respond to C+D before its deadline but pharmacy minister Earl Howe told C+D in August that he believed the supply chain did "generally work very smoothly" and that the DH's medicines supply chain group continued to review the information on shortages that it received from PSNC and Pharmacy Voice.

C+D is compiling evidence of medicines shortages to present to Earl Howe, in response to his call for pharmacists to prove that stock shortages were harming patients.


Do you have evidence of stock shortages causing patient harm that we can show to Earl Howe?

Topics



Pharmacy Dispenser/ Technician
Bethnal Green North, London
Salary: Up to £30,000

Apply Now
UsernamePublicRestriction

Register

CD016609

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel